Panacea Medical Technologies key facts
as of Oct 2026- Manufacturer of digital radiography and mammography equipment designed to enhance cancer care.
- Panacea Medical Technologies is valued at approximately $74.0M as of Oct 2026 (last reported valuation).
- It has raised $15.3M; the latest was PE Growth/Expansion ($5.8M) in Feb 2025.
- Notable investors include New Enterprise Associates, Claypond Capital Partners, IL&FS Investment Managers, MegaDelta Capital Advisors.
- Status: Privately Held (backing).
Panacea Medical Technologies's last reported valuation, Feb 2025. Nothing priced has surfaced since.
- ·Watch Panacea Medical Technologies: the Monday email on marks, rounds and moves
Panacea Medical Technologies funding rounds
No funding rounds for Panacea Medical Technologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Panacea Medical Technologies
4Panacea Medical Technologies valuation
Panacea Medical Technologies's last reported valuation was $74 million in Feb 2025. No priced round, secondary trade or fund mark has surfaced since.
Panacea Medical Technologies investors
4 investors are on record for Panacea Medical Technologies, including New Enterprise Associates, Claypond Capital Partners, IL&FS Investment Managers and MegaDelta Capital Advisors.
About Panacea Medical Technologies
Manufacturer of digital radiography and mammography equipment designed to enhance cancer care. The company offers products including multileaf collimators, simulator systems, patient positioning systems, and other medical equipment for radiation therapy and localization of treatment areas, enabling radiotherapy and radiology centers to enhance their treatment techniques.
- Sector
- Healthcare
- HQ
- Kolar, India
- Founded
- 1999
- Employees
- 450
- Website
- panaceamedical.in/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.